Bannayan-Riley-Ruvalcaba syndrome classification: Difference between revisions

Jump to navigation Jump to search
Gunnam (talk | contribs)
Gunnam (talk | contribs)
Line 5: Line 5:
{{CMG}}; {{AE}} {{VKG}}
{{CMG}}; {{AE}} {{VKG}}
==Overview==
==Overview==
There is no established system for the [[classification]] of [[Bannayan-Riley-Ruvalcaba syndrome]] (BRRS).
[[Bannayan-Riley-Ruvalcaba syndrome]] (BRRS) is one of the syndrome which belong to [[PTEN (gene)|PTEN]] [[hamartoma]] tumor syndromes (PHTS).


==Classification==
==Classification==

Revision as of 15:51, 19 April 2019


Template:Bannayan-Riley-Ruvalcaba syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]

Overview

Bannayan-Riley-Ruvalcaba syndrome (BRRS) is one of the syndrome which belong to PTEN hamartoma tumor syndromes (PHTS).

Classification

Bannayan-Riley-Ruvalcaba syndrome (BRRS) is one of the syndrome which belong to PTEN hamartoma tumor syndromes (PHTS). These syndrome has been due to somatic mutation in phosphatase and tensin homolog (PTEN) gene. All PTEN hamartoma tumor syndromes (PHTS) follow autosomal dominant pattern of inheritance. PTENhamartoma tumor syndromes (PHTS) include the following:[1]

References

  1. Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, Bodurtha J, Crowe C, Curtis MA, Dasouki M, Dunn T, Feit H, Geraghty MT, Graham JM, Hodgson SV, Hunter A, Korf BR, Manchester D, Miesfeldt S, Murday VA, Nathanson KL, Parisi M, Pober B, Romano C, Eng C (August 1999). "PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome". Hum. Mol. Genet. 8 (8): 1461–72. PMID 10400993.

Template:WH Template:WS